Zonisamide-induced weight loss in schizophrenia: Case series

Jaewon Yang, Moon-Soo Lee, Sook Haeng Joe, In Kwa Jung, Seung Hyun Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

Original languageEnglish
Pages (from-to)104-106
Number of pages3
JournalClinical Neuropharmacology
Volume33
Issue number2
DOIs
Publication statusPublished - 2010 Mar 1

Fingerprint

zonisamide
Weight Loss
Schizophrenia
Waist Circumference
Antipsychotic Agents
Weight Gain
Life Style
Exercise

Keywords

  • Obesity
  • Schizophrenia
  • Waist circumference
  • Weight loss
  • Zonisamide

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Zonisamide-induced weight loss in schizophrenia : Case series. / Yang, Jaewon; Lee, Moon-Soo; Joe, Sook Haeng; Jung, In Kwa; Kim, Seung Hyun.

In: Clinical Neuropharmacology, Vol. 33, No. 2, 01.03.2010, p. 104-106.

Research output: Contribution to journalArticle

Yang, Jaewon ; Lee, Moon-Soo ; Joe, Sook Haeng ; Jung, In Kwa ; Kim, Seung Hyun. / Zonisamide-induced weight loss in schizophrenia : Case series. In: Clinical Neuropharmacology. 2010 ; Vol. 33, No. 2. pp. 104-106.
@article{8626868fd12b40429c2a50b6d67e82a5,
title = "Zonisamide-induced weight loss in schizophrenia: Case series",
abstract = "Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.",
keywords = "Obesity, Schizophrenia, Waist circumference, Weight loss, Zonisamide",
author = "Jaewon Yang and Moon-Soo Lee and Joe, {Sook Haeng} and Jung, {In Kwa} and Kim, {Seung Hyun}",
year = "2010",
month = "3",
day = "1",
doi = "10.1097/WNF.0b013e3181c848a0",
language = "English",
volume = "33",
pages = "104--106",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Zonisamide-induced weight loss in schizophrenia

T2 - Case series

AU - Yang, Jaewon

AU - Lee, Moon-Soo

AU - Joe, Sook Haeng

AU - Jung, In Kwa

AU - Kim, Seung Hyun

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

AB - Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

KW - Obesity

KW - Schizophrenia

KW - Waist circumference

KW - Weight loss

KW - Zonisamide

UR - http://www.scopus.com/inward/record.url?scp=77951071549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951071549&partnerID=8YFLogxK

U2 - 10.1097/WNF.0b013e3181c848a0

DO - 10.1097/WNF.0b013e3181c848a0

M3 - Article

C2 - 19935403

AN - SCOPUS:77951071549

VL - 33

SP - 104

EP - 106

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 2

ER -